Trial intelligence / Profile preview

Indocyanine green near-infrared fluorescence sentinel lymph node mapping in endometrial and cervical cancer

jRCTs031180426Completed

Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green in endometrial cancer (EC) and Cervical Cancer (CC). Primary endpoint: Sentinel lymph node detection rate. Started Nov 2016; status: completed.

02

Drugs

indocyanine green
03

Conditions

endometrial cancer (EC)Cervical Cancer (CC)

Beyond the preview

Go deeper on jRCTs031180426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call